Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1901770 Title: UTILISATION DE L'HORMONE DE CROISSANCE ET DE L'IGF-1 POUR TRAITER LES TROUBLES DE LA CROISSANCE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
067845297
WO application number:
US2006021282
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
1901770
WO publication number:
WO2006130769
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
01/06/2006
Grant date:
24/12/2014
EP publication date:
26/03/2008
WO publication date:
07/12/2006
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
24/12/2014
EP B1 publication date:
24/12/2014
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
01/06/2026

Applicant

Name:
Ipsen Biopharmaceuticals, Inc.
Legal Form:
From:
24/12/2014
Address:
2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005, United States (US)
To:

Inventor

Name:
CLARK, Ross G.
Legal Form:
Address:
Auckland, New Zealand (NZ)

Priority

Priority patent number:
687617 P
Priority date:
02/06/2005
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 14/65; A61K 38/27; A61K 38/30; A61P 5/06;

Publication

European Patent Bulletin

Issue number:
201452
Publication date:
24/12/2014
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/12/2015
Annual fee number:
10
Annual fee amount:
170 Euro
Penalty fee amount:
75 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type